Skip to main content

ʻO nā mea e pono ai ʻoe e ʻike e pili ana i ka lāʻau pale ʻo Inebilizumab no ka Neuromyelitis Optica Spectrum Disorder (NMOSD)

ʻO nā mea e pono ai ʻoe e ʻike e pili ana i ka lāʻau pale ʻo Inebilizumab no ka Neuromyelitis Optica Spectrum Disorder (NMOSD)

Loaʻa iā ʻoe a i ʻole kekahi āu i ʻike ai ka Neuromyelitis Optica Spectrum Disorder (NMOSD)? Inā pēlā, ua haʻi aku paha kāu kauka iā ʻoe e pili ana i kahi lāʻau pale i kapa ʻia ʻo Inebilizumab (puana ʻia: ee-ne-bi-li-su-mab). Hiki ke hopohopo iki ka lohe ʻana i kahi inoa e like me ia. Akā, mai hopohopo. I kēia lā, e kamaʻilio mākou e pili ana i kēia lāʻau, kāna hana, a me nā mea āu e pono ai e makaʻala i ka wā e hoʻohana ai.

No laila, he aha kēia lāʻau i kapa ʻia ʻo Inebilizumab?

I ka ʻōlelo maʻalahi, ʻo `Inebilizumab` (inoa inoa: UPLIZNA) he protein kūikawā. I ka ʻepekema lapaʻau, kapa mākou i kēia he `monoclonal antibody`. ʻO kāna hana nui ka kaohi ʻana i ke ʻano maʻi `Neuromyelitis Optica Spectrum Disorder (NMOSD)`.

ʻO NMOSD kahi kūlana kahi e hoʻouka ai ka ʻōnaehana pale o ko mākou kino i kāna mau hunaola nerve ponoʻī, ʻoiai nā mea i loko o nā maka a me ke kaula kuamoʻo. No laila, ʻo ka hana a kēia lāʻau lapaʻau ʻInebilizumab ʻo ia ke kuhikuhi i kēlā hana ʻōnaehana pale hewa, hoʻōki iā ia, a hoʻēmi i ka pōʻino i hana ʻia e ka maʻi.

Hiki i kāu kauka ke kuhikuhi i kēia lāʻau lapaʻau no nā kūlana ʻē aʻe, no laila inā he mau hopohopo kāu, e ʻoluʻolu e nīnau i kāu kauka e pili ana i ia mea.

Nā mea e pono ai ʻoe e haʻi i kāu kauka ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau

Ma mua o ka hoʻomaka ʻana i kēia lāʻau lapaʻau, he mea nui loa ia e hoʻomaopopo i kāu kauka e pili ana i kou mōʻaukala olakino piha. Ma ke ʻano kūikawā, pono ʻoe e haʻi iā ia e pili ana i kēia mau mea.

Nā mea e pono ai ʻoe e ʻike No ke aha mai kēlā? (ʻAʻole maopopo)
Nā pilikia o ka ʻōnaehana pale: Inā he mau nāwaliwali ʻē aʻe kou. Ma muli o ka hoʻololi ʻana o kēia lāʻau lapaʻau i ka hana o ka ʻōnaehana pale, he mea nui e makaʻala i nā pilikia e kū nei.
Nā maʻi o kēia manawa: Inā loaʻa iā ʻoe ke kuni, ke anu, ka ʻūhā, a i ʻole kahi maʻi viral e like me ka chickenpox a i ʻole herpes.Hoʻemi kēia lāʻau lapaʻau i kou hiki ke hakakā i nā maʻi, no laila e ʻoi aku ka ʻino o kahi maʻi e kū nei.
Nā maʻi ʻaleka: Inā he maʻi ʻaleka kou i ka Inebilizumab a i ʻole nā ​​lāʻau lapaʻau ʻē aʻe, nā meaʻai, a i ʻole nā ​​​​​​mea hoʻoluʻu. He mea nui kēia e pale ai i kahi hopena alerika koʻikoʻi e hiki mai ana i ka wā e lawelawe ʻia ai ka lāʻau lapaʻau.
Hāpai keiki: Inā hāpai ʻoe, e hoʻāʻo ana e hāpai, a hānai waiū paha. Hiki i kēia lāʻau lapaʻau ke hoʻopilikia i ka pēpē i loko o ka ʻōpū, no laila he mea nui loa ke kamaʻilio e pili ana i kēia.

Pehea e hiki ai iaʻu ke hāʻawi iā ʻoe i kēia lāʻau lapaʻau?

ʻAʻole ʻo "Inebilizumab" he lāʻau lapaʻau e lawe ʻia ma ka home. He inikini ia i hāʻawi ʻia ma o kahi aʻa me ka saline (infusion intravenous) . Hāʻawi ʻia kēia lāʻau lapaʻau ma kahi haukapila a i ʻole ke keʻena lapaʻau ma lalo o ka nānā ʻana o nā limahana lapaʻau i aʻo ʻia.

Ma mua o ka mālama ʻana, hiki ke hāʻawi ʻia iā ʻoe nā lāʻau lapaʻau ʻē aʻe (no ka laʻana, nā lāʻau lapaʻau allergy) e hōʻemi i ka pilikia o nā hopena allergic i ka lāʻau.

Ma mua o kēlā me kēia kau lapaʻau, e hāʻawi ʻia ʻoe i kahi pepa ʻike kūikawā (`MedGuide`) e pili ana i kēia lāʻau lapaʻau. He mea nui e heluhelu a hoʻomaopopo pono iā ia i kēlā me kēia manawa.

He aha inā e piʻi aʻe ka nui o ka lāʻau?

Hāʻawi ʻia kēia ma kahi haukapila, no laila ua haʻahaʻa loa ka manawa e hiki ai kēia. Eia nō naʻe, inā manaʻo ʻoe ua lawe nui ʻoe i ka lāʻau lapaʻau, e hoʻomaopopo koke i nā limahana lapaʻau. A i ʻole, e kelepona i ke Kikowaena ʻIke Poisons National ma ka Halemai Lahui ʻo Colombo . A i ʻole e hele i ka Emergency Treatment Unit (ETU) o ka haukapila kokoke loa.

He aha inā e hala wau i ka lā e lawe ai i ka lāʻau lapaʻau?

Hāʻawi ʻia kēia lāʻau lapaʻau ma ke ʻano i hoʻonohonoho ʻia. No laila, he mea nui loa ka loaʻa ʻana o ka lāʻau lapaʻau i ka manawa kūpono. Inā no kekahi kumu ʻaʻole hiki iā ʻoe ke hele i kāu lā i hoʻonohonoho ʻia, e kelepona koke i kāu kauka a i ʻole ka haukapila a e hoʻomaopopo iā lākou, i hiki iā lākou ke hoʻonohonoho i kahi manawa no ka lā e hiki mai ana.

Nā mea āu e makaʻala nui ai i ka wā e lawe ana i ka lāʻau lapaʻau

E nānā pono kāu kauka iā ʻoe i kou wā e lawe ana i kēia lāʻau lapaʻau, a he mea nui iā ʻoe e makaʻala i kēia mau mea.

  • Ka pilikia o ka maʻi: No ka mea, ua kāohi kēia lāʻau i kāu ʻōnaehana pale i kekahi ʻano, hiki iā ʻoe ke piʻi aʻe ka pilikia o ka maʻi . Inā loaʻa iā ʻoe kekahi mau hōʻailona o ka maʻi e like me ke kuni, ke anu, ka ʻāʻī ʻeha, ke kuni, nā hōʻailona anu, a i ʻole ka ʻeha i ka wā e mimi ai,E haʻi koke aku i kāu kauka. Mai hoʻōla ponoʻī. E hoʻāʻo e noho mamao aku mai ka poʻe maʻi.
  • Nā hopena maʻi koʻikoʻi: Loaʻa paha i kekahi poʻe kahi hopena maʻi koʻikoʻi i kēia lāʻau lapaʻau. Inā loaʻa iā ʻoe kekahi ʻulaʻula ʻili, maneʻo, pehu o ka maka, nā lehelehe, a i ʻole ke alelo i ka wā a ma hope koke iho paha o ka inikini ʻana, e hoʻomaopopo koke i ke limahana lapaʻau.
  • Ke pale ʻana i ka hāpai ʻana: Inā he wahine ʻoe, e pale i ka hāpai ʻana i ka wā e lawe ana i kēia lāʻau lapaʻau a no 6 mau mahina ma hope o ka hoʻōki ʻana i ka lāʻau lapaʻau . Hiki i kēia lāʻau lapaʻau ke hōʻeha nui i kahi pēpē i hānau ʻole ʻia. Inā ʻoe e hoʻolālā ana e hāpai, e kamaʻilio me kāu kauka e pili ana i ia mea.

Hoʻomaopopo Kūikawā: He mea kākaʻikahi loa, hiki i kēia lāʻau lapaʻau ke hoʻoulu i kahi maʻi koʻikoʻi a hoʻoweliweli i ke ola o ka lolo (i kapa ʻia ʻo 'Progressive Multifocal Leukoencephalopathy - PML`) i kekahi poʻe. No laila, inā loaʻa iā ʻoe kekahi pilikia a loli paha i kou ʻike, noʻonoʻo, ʻōlelo, hele wāwae, a i ʻole ke kaulike , e haʻi koke i kāu kauka .

Nā hopena ʻaoʻao o ka lāʻau lapaʻau

E like me nā lāʻau lapaʻau āpau, hiki i ka ʻInebilizumab ke hana i kekahi mau hopena ʻaoʻao. Pono e hōʻike koke ʻia kekahi o kēia mau mea, a ʻo kekahi ʻaʻole koʻikoʻi loa.

Nā hopena ʻaoʻao e pono ʻoe e hōʻike koke i kāu kauka
Nā maʻi ʻaleʻale koʻikoʻi ʻŌhūhū ʻili, maneʻo, pehu o ka maka, nā lehelehe, ke alelo, paʻakikī ka hanu ʻana.
Nā hōʻailona o ka maʻi Kuni, anu, ʻeha ka ʻāʻī, kuʻi, maʻi ʻōpū mimi.
ʻAʻole maʻamau ka koʻikoʻi (akā e haʻi i kāu kauka inā hoʻomau ia)
ʻEha kino ʻEha kua, ʻeha hono.
ʻEha poʻo ʻEha poʻo iki a kaulike.
ʻO ka ʻoluʻolu ʻole ma kahi i hoʻokomo ʻia ʻEha, ʻulaʻula, a pehu paha ma kahi i inikini ʻia.

ʻAʻole i loko o kēia papa inoa nā hopena ʻaoʻao āpau. Eia kekahi, inā loaʻa iā ʻoe kekahi mea ʻē, e kamaʻilio me kāu kauka e pili ana i ia mea.

Leka Lawe-Home

  • He lāʻau lapaʻau kūikawā ʻo `Inebilizumab` i hāʻawi ʻia ma o kahi aʻa koko ma kahi haukapila no `Neuromyelitis Optica Spectrum Disorder (NMOSD).`
  • Ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau, e haʻi i kāu kauka e pili ana i kou mau maʻi āpau, nā maʻi allergies, a me nā lāʻau lapaʻau ʻē aʻe āu e lawe nei.
  • Inā loaʻa iā ʻoe nā hōʻailona o ka maʻi e like me ke kuni a me ke kuni i ka wā e lawe ana i kēia lāʻau lapaʻau, e ʻimi koke i ke kōkua lapaʻau.
  • Mai hāpai i ka wā o ka lāʻau lapaʻau a no 6 mau mahina ma hope o ka hoʻōki ʻana. E kamaʻilio me kāu kauka e pili ana i kēia.
  • Mai makaʻu e noi i kāu kauka no ka wehewehe ʻana i nā pilikia a kānalua paha āu e loaʻa ai. Aia lākou ma laila e kōkua iā ʻoe.

ʻInebilizumab, UPLIZNA, Neuromyelitis Optica, NMOSD, monoclonal antibody, nā hopena ʻaoʻao, Inebilizumab, lāʻau pale, maʻi neurological, nā hopena ʻaoʻao, lapaʻau, lāʻau lapaʻau NMOSD

Frequently Asked Questions (FAQ)

He aha inā e hala wau i ka lā e lawe ai i ka lāʻau lapaʻau?

Hāʻawi ʻia kēia lāʻau lapaʻau ma ke ʻano i hoʻonohonoho ʻia. No laila, he mea nui loa ka loaʻa ʻana o ka lāʻau lapaʻau i ka manawa kūpono. Inā no kekahi kumu ʻaʻole hiki iā ʻoe ke hele i kāu lā i hoʻonohonoho ʻia, e kelepona koke i kāu kauka a i ʻole ka haukapila a e hoʻomaopopo iā lākou, i hiki iā lākou ke hoʻonohonoho i kahi manawa no ka lā e hiki mai ana.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

ʻAʻohe manaʻo i kau ʻia. Hoʻohui i kāu manaʻo ma ʻaneʻi no ka manawa mua.

Hoʻohui i kāu manaʻo

E ʻoluʻolu e helu: 3 + 8 =
ʻO nā mea e pono ai ʻoe e ʻike e pili ana i ka lāʻau pale ʻo Inebilizumab no ka Neuromyelitis Optica Spectrum Disorder (NMOSD)

ʻO nā mea e pono ai ʻoe e ʻike e pili ana i ka lāʻau pale ʻo Inebilizumab no ka Neuromyelitis Optica Spectrum Disorder (NMOSD)

Loaʻa iā ʻoe a i ʻole kekahi āu i ʻike ai ka Neuromyelitis Optica Spectrum Disorder (NMOSD)? Inā pēlā, ua haʻi aku paha kāu kauka iā ʻoe e pili ana i kahi lāʻau pale i kapa ʻia ʻo Inebilizumab (puana ʻia: ee-ne-bi-li-su-mab). Hiki ke hopohopo iki ka lohe ʻana i kahi inoa e like me ia. Akā, mai hopohopo. I kēia lā, e kamaʻilio mākou e pili ana i kēia lāʻau, kāna hana, a me nā mea āu e pono ai e makaʻala i ka wā e hoʻohana ai.

No laila, he aha kēia lāʻau i kapa ʻia ʻo Inebilizumab?

I ka ʻōlelo maʻalahi, ʻo `Inebilizumab` (inoa inoa: UPLIZNA) he protein kūikawā. I ka ʻepekema lapaʻau, kapa mākou i kēia he `monoclonal antibody`. ʻO kāna hana nui ka kaohi ʻana i ke ʻano maʻi `Neuromyelitis Optica Spectrum Disorder (NMOSD)`.

ʻO NMOSD kahi kūlana kahi e hoʻouka ai ka ʻōnaehana pale o ko mākou kino i kāna mau hunaola nerve ponoʻī, ʻoiai nā mea i loko o nā maka a me ke kaula kuamoʻo. No laila, ʻo ka hana a kēia lāʻau lapaʻau ʻInebilizumab ʻo ia ke kuhikuhi i kēlā hana ʻōnaehana pale hewa, hoʻōki iā ia, a hoʻēmi i ka pōʻino i hana ʻia e ka maʻi.

Hiki i kāu kauka ke kuhikuhi i kēia lāʻau lapaʻau no nā kūlana ʻē aʻe, no laila inā he mau hopohopo kāu, e ʻoluʻolu e nīnau i kāu kauka e pili ana i ia mea.

Nā mea e pono ai ʻoe e haʻi i kāu kauka ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau

Ma mua o ka hoʻomaka ʻana i kēia lāʻau lapaʻau, he mea nui loa ia e hoʻomaopopo i kāu kauka e pili ana i kou mōʻaukala olakino piha. Ma ke ʻano kūikawā, pono ʻoe e haʻi iā ia e pili ana i kēia mau mea.

Nā mea e pono ai ʻoe e ʻike No ke aha mai kēlā? (ʻAʻole maopopo)
Nā pilikia o ka ʻōnaehana pale: Inā he mau nāwaliwali ʻē aʻe kou. Ma muli o ka hoʻololi ʻana o kēia lāʻau lapaʻau i ka hana o ka ʻōnaehana pale, he mea nui e makaʻala i nā pilikia e kū nei.
Nā maʻi o kēia manawa: Inā loaʻa iā ʻoe ke kuni, ke anu, ka ʻūhā, a i ʻole kahi maʻi viral e like me ka chickenpox a i ʻole herpes.Hoʻemi kēia lāʻau lapaʻau i kou hiki ke hakakā i nā maʻi, no laila e ʻoi aku ka ʻino o kahi maʻi e kū nei.
Nā maʻi ʻaleka: Inā he maʻi ʻaleka kou i ka Inebilizumab a i ʻole nā ​​lāʻau lapaʻau ʻē aʻe, nā meaʻai, a i ʻole nā ​​​​​​mea hoʻoluʻu. He mea nui kēia e pale ai i kahi hopena alerika koʻikoʻi e hiki mai ana i ka wā e lawelawe ʻia ai ka lāʻau lapaʻau.
Hāpai keiki: Inā hāpai ʻoe, e hoʻāʻo ana e hāpai, a hānai waiū paha. Hiki i kēia lāʻau lapaʻau ke hoʻopilikia i ka pēpē i loko o ka ʻōpū, no laila he mea nui loa ke kamaʻilio e pili ana i kēia.

Pehea e hiki ai iaʻu ke hāʻawi iā ʻoe i kēia lāʻau lapaʻau?

ʻAʻole ʻo "Inebilizumab" he lāʻau lapaʻau e lawe ʻia ma ka home. He inikini ia i hāʻawi ʻia ma o kahi aʻa me ka saline (infusion intravenous) . Hāʻawi ʻia kēia lāʻau lapaʻau ma kahi haukapila a i ʻole ke keʻena lapaʻau ma lalo o ka nānā ʻana o nā limahana lapaʻau i aʻo ʻia.

Ma mua o ka mālama ʻana, hiki ke hāʻawi ʻia iā ʻoe nā lāʻau lapaʻau ʻē aʻe (no ka laʻana, nā lāʻau lapaʻau allergy) e hōʻemi i ka pilikia o nā hopena allergic i ka lāʻau.

Ma mua o kēlā me kēia kau lapaʻau, e hāʻawi ʻia ʻoe i kahi pepa ʻike kūikawā (`MedGuide`) e pili ana i kēia lāʻau lapaʻau. He mea nui e heluhelu a hoʻomaopopo pono iā ia i kēlā me kēia manawa.

He aha inā e piʻi aʻe ka nui o ka lāʻau?

Hāʻawi ʻia kēia ma kahi haukapila, no laila ua haʻahaʻa loa ka manawa e hiki ai kēia. Eia nō naʻe, inā manaʻo ʻoe ua lawe nui ʻoe i ka lāʻau lapaʻau, e hoʻomaopopo koke i nā limahana lapaʻau. A i ʻole, e kelepona i ke Kikowaena ʻIke Poisons National ma ka Halemai Lahui ʻo Colombo . A i ʻole e hele i ka Emergency Treatment Unit (ETU) o ka haukapila kokoke loa.

He aha inā e hala wau i ka lā e lawe ai i ka lāʻau lapaʻau?

Hāʻawi ʻia kēia lāʻau lapaʻau ma ke ʻano i hoʻonohonoho ʻia. No laila, he mea nui loa ka loaʻa ʻana o ka lāʻau lapaʻau i ka manawa kūpono. Inā no kekahi kumu ʻaʻole hiki iā ʻoe ke hele i kāu lā i hoʻonohonoho ʻia, e kelepona koke i kāu kauka a i ʻole ka haukapila a e hoʻomaopopo iā lākou, i hiki iā lākou ke hoʻonohonoho i kahi manawa no ka lā e hiki mai ana.

Nā mea āu e makaʻala nui ai i ka wā e lawe ana i ka lāʻau lapaʻau

E nānā pono kāu kauka iā ʻoe i kou wā e lawe ana i kēia lāʻau lapaʻau, a he mea nui iā ʻoe e makaʻala i kēia mau mea.

  • Ka pilikia o ka maʻi: No ka mea, ua kāohi kēia lāʻau i kāu ʻōnaehana pale i kekahi ʻano, hiki iā ʻoe ke piʻi aʻe ka pilikia o ka maʻi . Inā loaʻa iā ʻoe kekahi mau hōʻailona o ka maʻi e like me ke kuni, ke anu, ka ʻāʻī ʻeha, ke kuni, nā hōʻailona anu, a i ʻole ka ʻeha i ka wā e mimi ai,E haʻi koke aku i kāu kauka. Mai hoʻōla ponoʻī. E hoʻāʻo e noho mamao aku mai ka poʻe maʻi.
  • Nā hopena maʻi koʻikoʻi: Loaʻa paha i kekahi poʻe kahi hopena maʻi koʻikoʻi i kēia lāʻau lapaʻau. Inā loaʻa iā ʻoe kekahi ʻulaʻula ʻili, maneʻo, pehu o ka maka, nā lehelehe, a i ʻole ke alelo i ka wā a ma hope koke iho paha o ka inikini ʻana, e hoʻomaopopo koke i ke limahana lapaʻau.
  • Ke pale ʻana i ka hāpai ʻana: Inā he wahine ʻoe, e pale i ka hāpai ʻana i ka wā e lawe ana i kēia lāʻau lapaʻau a no 6 mau mahina ma hope o ka hoʻōki ʻana i ka lāʻau lapaʻau . Hiki i kēia lāʻau lapaʻau ke hōʻeha nui i kahi pēpē i hānau ʻole ʻia. Inā ʻoe e hoʻolālā ana e hāpai, e kamaʻilio me kāu kauka e pili ana i ia mea.

Hoʻomaopopo Kūikawā: He mea kākaʻikahi loa, hiki i kēia lāʻau lapaʻau ke hoʻoulu i kahi maʻi koʻikoʻi a hoʻoweliweli i ke ola o ka lolo (i kapa ʻia ʻo 'Progressive Multifocal Leukoencephalopathy - PML`) i kekahi poʻe. No laila, inā loaʻa iā ʻoe kekahi pilikia a loli paha i kou ʻike, noʻonoʻo, ʻōlelo, hele wāwae, a i ʻole ke kaulike , e haʻi koke i kāu kauka .

Nā hopena ʻaoʻao o ka lāʻau lapaʻau

E like me nā lāʻau lapaʻau āpau, hiki i ka ʻInebilizumab ke hana i kekahi mau hopena ʻaoʻao. Pono e hōʻike koke ʻia kekahi o kēia mau mea, a ʻo kekahi ʻaʻole koʻikoʻi loa.

Nā hopena ʻaoʻao e pono ʻoe e hōʻike koke i kāu kauka
Nā maʻi ʻaleʻale koʻikoʻi ʻŌhūhū ʻili, maneʻo, pehu o ka maka, nā lehelehe, ke alelo, paʻakikī ka hanu ʻana.
Nā hōʻailona o ka maʻi Kuni, anu, ʻeha ka ʻāʻī, kuʻi, maʻi ʻōpū mimi.
ʻAʻole maʻamau ka koʻikoʻi (akā e haʻi i kāu kauka inā hoʻomau ia)
ʻEha kino ʻEha kua, ʻeha hono.
ʻEha poʻo ʻEha poʻo iki a kaulike.
ʻO ka ʻoluʻolu ʻole ma kahi i hoʻokomo ʻia ʻEha, ʻulaʻula, a pehu paha ma kahi i inikini ʻia.

ʻAʻole i loko o kēia papa inoa nā hopena ʻaoʻao āpau. Eia kekahi, inā loaʻa iā ʻoe kekahi mea ʻē, e kamaʻilio me kāu kauka e pili ana i ia mea.

Leka Lawe-Home

  • He lāʻau lapaʻau kūikawā ʻo `Inebilizumab` i hāʻawi ʻia ma o kahi aʻa koko ma kahi haukapila no `Neuromyelitis Optica Spectrum Disorder (NMOSD).`
  • Ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau, e haʻi i kāu kauka e pili ana i kou mau maʻi āpau, nā maʻi allergies, a me nā lāʻau lapaʻau ʻē aʻe āu e lawe nei.
  • Inā loaʻa iā ʻoe nā hōʻailona o ka maʻi e like me ke kuni a me ke kuni i ka wā e lawe ana i kēia lāʻau lapaʻau, e ʻimi koke i ke kōkua lapaʻau.
  • Mai hāpai i ka wā o ka lāʻau lapaʻau a no 6 mau mahina ma hope o ka hoʻōki ʻana. E kamaʻilio me kāu kauka e pili ana i kēia.
  • Mai makaʻu e noi i kāu kauka no ka wehewehe ʻana i nā pilikia a kānalua paha āu e loaʻa ai. Aia lākou ma laila e kōkua iā ʻoe.

ʻInebilizumab, UPLIZNA, Neuromyelitis Optica, NMOSD, monoclonal antibody, nā hopena ʻaoʻao, Inebilizumab, lāʻau pale, maʻi neurological, nā hopena ʻaoʻao, lapaʻau, lāʻau lapaʻau NMOSD

Frequently Asked Questions (FAQ)

He aha inā e hala wau i ka lā e lawe ai i ka lāʻau lapaʻau?

Hāʻawi ʻia kēia lāʻau lapaʻau ma ke ʻano i hoʻonohonoho ʻia. No laila, he mea nui loa ka loaʻa ʻana o ka lāʻau lapaʻau i ka manawa kūpono. Inā no kekahi kumu ʻaʻole hiki iā ʻoe ke hele i kāu lā i hoʻonohonoho ʻia, e kelepona koke i kāu kauka a i ʻole ka haukapila a e hoʻomaopopo iā lākou, i hiki iā lākou ke hoʻonohonoho i kahi manawa no ka lā e hiki mai ana.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

ʻAʻohe manaʻo i kau ʻia. Hoʻohui i kāu manaʻo ma ʻaneʻi no ka manawa mua.

Hoʻohui i kāu manaʻo

E ʻoluʻolu e helu: 3 + 8 =